Patents Assigned to Tandem Diabetes Care, Inc.
  • Patent number: 11969576
    Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: April 30, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
  • Patent number: 11967292
    Abstract: An apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a color display. Color on the display can be used to bring a user's attention to a change in status of the device or a detected change in status of the patient.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: April 23, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Patent number: 11951284
    Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
  • Patent number: 11956225
    Abstract: Systems and methods for controlling a peripheral device with a web browser. A system includes a peripheral device and a user computing device executing a web browser and a device manager, the device manager configured to operate the peripheral device and including a device manager web server. An authentication token can be passed to the web browser from a web server upon coupling of the peripheral device with the user computing device and login by the user with the web browser. The web browser can pass the authentication token to the device manager through the device manager web server. The device manager can transmit the authentication token to the web server to pair the web browser with the device manager.
    Type: Grant
    Filed: October 10, 2022
    Date of Patent: April 9, 2024
    Assignee: TANDEM DIABETES CARE, INC.
    Inventor: Robert Windsor Gillespie
  • Patent number: 11911595
    Abstract: Disclosed herein are apparatuses and methods that account for meal announcements in closed loop insulin delivery systems. Rather than simply increasing an insulin delivery rate in response to the meal announcement, the closed loop algorithm can be modified to increase the insulin on board tolerance during eating periods. This approach utilizes the stability of the cascaded loop in the closed loop algorithm to prevent the oscillations in glucose levels that can occur by simply increasing the basal rate.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: February 27, 2024
    Assignee: TANDEM DIABETES CARE, INC.
    Inventors: Thomas R. Ulrich, Virginia S. Lu
  • Patent number: 11911590
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: February 27, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Patent number: 11896799
    Abstract: Infusion devices, systems, and methods can for detecting a presence or an absence of an infusion cartridge in an infusion pump. Embodiments may include a loading sequence, recording loading pulse width modulation (PWM) commands applied to an infusion pump motor during the loading sequence, setting a value of threshold PWM commands based on the loading PWM commands applied during the loading sequence and comparing values of operational PWM commands applied during pumping operations to the value of the threshold PWM commands. If the values of the operational PWM commands drops below the value of the threshold PWM commands by a predetermined amount, a missing infusion cartridge warning may be generated.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: February 13, 2024
    Assignee: TANDEM DIABETES CARE, INC.
    Inventor: Geoffrey Kruse
  • Patent number: 11872368
    Abstract: Methods and systems are disclosed wherein temperature in a device such as an ambulatory infusion pump is monitored during inductive charging of the device such that temperature-sensitive contents or components, such as, for example, insulin, particular circuitry and/or other components are not damaged. Temperature can be monitored in the device at one or more locations during inductive charging. If the temperature breaches one or more predetermined thresholds and/or is rising at a rate greater than one or more predetermined thresholds, charging can be suspended or provided at reduced power to prevent the temperature from further rising and damaging the contents and/or components of the device. One or more alerts associated with these events may also be triggered so that the user is aware of the situation and may take corrective action.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: January 16, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Caleb Butler, Robert Eastridge, Michael Michaud, Philip S. Lamb, Geoffrey A. Kruse
  • Patent number: 11869650
    Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
  • Patent number: 11857764
    Abstract: Missed meal bolus reminders or alerts require a user to access the user's pump and/or remote control to clear the reminder/alert even when the user skipped a meal such that no meal bolus was needed. CGM data can be leveraged such that the missed meal bolus alert is only triggered when glucose levels rise in response to consuming the meal within the programmed time window. Therefore, the alert is only provided when a meal is actually consumed and no bolus has been delivered. This further allows the user to be alerted sooner, i.e., as soon as glucose levels rise a predetermined amount or passed a predetermined threshold indicating consumption of a meal as opposed to only at the end of the programmed window.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: January 2, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Paul Harris
  • Patent number: 11850394
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver a fluid, a wireless communication port, a controller, and a housing to enclose the apparatus. The controller is configured to communicate with a second device via the communication port using an open standard wireless communication protocol. The housing includes a mechanical coupling to slidably engage the second device which includes a second wireless communication port. Slidably engaging the second device positions the first and second communication ports opposite each other to allow communication via the first and second communication ports when slidably engaged.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: December 26, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Blomquist, Timothy Bresina, William Van Dyke, Gail Beth Bynum, Michael Welsch
  • Patent number: 11848089
    Abstract: An apparatus comprising a controller. The controller includes an input/output (I/O) module and a rule module. The I/O module is configured to present a question for a patient when communicatively coupled to a user interface and receive patient information in response to the question via the user interface. The rule module is configured to apply a rule to the patient information and generate a suggested insulin pump setting from application of the rule. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: February 10, 2022
    Date of Patent: December 19, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael L. Blomquist
  • Patent number: 11838867
    Abstract: A battery-powered infusion pump for delivery of insulin or other medicament may collect and store data related to the pump. The infusion pump can communicate some or all of the stored data to another device, and control the timing and amount of data communicated in order to conserve battery life.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: December 5, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Geoffrey A Kruse
  • Patent number: 11830595
    Abstract: Disclosed herein are system and methods for organizing diabetes therapy data from different devices and across time changes that enable user analysis and visualization in a way that incorporates the changes in user time.
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: November 28, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Larkin Lowrey, Beau Randall, Tobias Lohse, Shaun Buchanan, Xavier de Anda, Jacob Kearns
  • Patent number: 11776689
    Abstract: Portable or ambulatory infusion devices and systems capable of remotely updating an ambulatory fluid delivery device include safety protocols that verify the status of the ambulatory fluid delivery device before and after a field update of software. Methods of accomplishing the same field update of software are also described.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: October 3, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Don Ludolph
  • Patent number: 11694794
    Abstract: Inadvertent activation of a portable medical device such as an ambulatory infusion pump can be reduced by locking a touchscreen of the device when it is indicated that an uninterrupted operation is to be performed. When a processor receives a device operation input from the touchscreen that indicates an uninterrupted operation is to be performed on the portable device, the touchscreen is automatically locked such that touch input at the touchscreen is not processed by the processor to navigate between or among menu screens or set pump parameters. Following completion of the uninterrupted operation, the touchscreen can be unlocked. In one embodiment, the touchscreen can be unlocked by selection of an unlock icon on the touchscreen.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: July 4, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason A. Farnan, Brian Bureson
  • Patent number: 11676694
    Abstract: Apparatuses and methods for training users of ambulatory medical devices. The methods relate to improving user interactions with the touchscreens of devices. In one embodiment there is an operating mode that records all user interactions along with various device parameters and allows the clinician to review the patient's performance for the initial use period. Automated analysis software may be employed to analyze the data generated by the device. The results of the analysis may be used by the clinician to improve the patient and device interaction.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: June 13, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Geoffrey A. Kruse, Kim Blickenstaff, Michael J. Rosinko
  • Patent number: 11654236
    Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: May 23, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
  • Patent number: D1010816
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Steven B. Cook, Philip Sven Lamb, Ryan William Betts, Michael Michaud
  • Patent number: D1014513
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: February 13, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason Farnan, Shaun Buchanan, Zion Greenlee